Karim Masri
Rheumatology · Richmond, VANPI 1336451038
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $114,946 of the $146,701 with a category attached, or 78.4%. 30 manufacturers reported payments, led by Amgen at 55.6% of the total. Reporting peaked in 2019 at $64,887 and has fallen 99.6% since, to $271 in 2022. Among rheumatology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 692 payments — averaging $212.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$82K
- Pfizer$31K
- Lilly USA, LLC$19K
- Novartis$11K
- AbbVie$1K
- Johnson & Johnson$483
- plus $3K from 24 others
What the payments were for
- Consulting fees$3,1502%
- Speaking & faculty fees$114,94678%
- Travel & lodging$16,77711%
- Food & beverage$11,7318%
- Education$960%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 209 | $81,575 |
| Pfizer | 130 | $30,735 |
| Lilly USA, LLC | 77 | $19,164 |
| Novartis | 39 | $10,512 |
| AbbVie | 63 | $1,206 |
| Johnson & Johnson | 28 | $483 |
| Mallinckrodt Hospital Products Inc. | 23 | $479 |
| AstraZeneca(2 entities) | 19 | $418 |
| Bristol Myers Squibb | 11 | $355 |
| E.r. Squibb & Sons, L.L.C. | 17 | $299 |
| Genentech USA, Inc. | 14 | $263 |
| GSK | 15 | $246 |
| Boehringer Ingelheim | 7 | $170 |
| Sanofi | 6 | $152 |
| Sobi, Inc | 5 | $121 |
| Regeneron Healthcare Solutions, Inc. | 5 | $96 |
| Mallinckrodt Enterprises LLC | 2 | $62 |
| Actelion Pharmaceuticals US, Inc. | 4 | $55 |
| Aurinia Pharma U.S., Inc. | 2 | $41 |
| Silvergate Pharmaceuticals, Inc. | 2 | $38 |
| Radius Health, Inc. | 2 | $36 |
| Ultragenyx Pharmaceutical Inc. | 2 | $32 |
| Oxford Immunotec USA Inc | 1 | $28 |
| Medexus Pharma, Inc. | 2 | $27 |
| Merck | 2 | $25 |
| UCB, Inc. | 1 | $18 |
| Bio Products Laboratory USA, Inc. | 1 | $18 |
| Boston Scientific | 1 | $16 |
| Hikma Pharmaceuticals USA | 1 | $15 |
| Gilead | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$146,701 in reported general payments places this provider in the 95th percentile of 159 rheumatology providers in Virginia.
Other rheumatology in Richmond
- Michael StrachanRichmond$158K
- Tammy SpringRichmond$17K
- Mihail MoroianuRichmond$13K
- Bhakti JoshiRichmond$12K
- Peter CoutlakisRichmond$12K
- Avnit AhujaRichmond$12K
- Steven MaestrelloRichmond$9K
- Peter LipskyCharlottesville$1.3M
- Kristi MizelleNewport News$1.1M
- Phillip KempfArlington$321K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.